Vondra K, Stárka L, Hampl R
Institute of Endocrinology, Prague, Czech Republic.
Physiol Res. 2015;64(Suppl 2):S95-S100. doi: 10.33549/physiolres.933083.
In this review we summarize recent opinions on the possible role of vitamin D in the risk of thyroid diseases development. It may be concluded from the available data that vitamin D deficiency, particularly levels below 12.5 ng/ml should be considered as an additional, but important risk factor for development of thyroid autoimmunity, both chronic autoimmune thyroiditis and Graves' disease. A higher risk of Graves' disease development is also associated with several polymorphisms in the gene encoding for vitamin D binding protein and for the specific receptor of active form of vitamin D - 1,25-(OH)(2)D(3) in the respective target cells. Important for development of thyroid cancer appeared polymorphisms of genes encoding for vitamin D receptors and of genes encoding for the participating hydroxylating enzymes in thyroid tissue, leading to a diminished local 1,25-(OH)(2)D(3) formation capacity with following alteration of antiproliferatory, antiapoptotic and prodifferentiating efficacy of the latter. Whether supplementation with high doses of vitamin D or its analogues possesses preventive or therapeutic effect is an object of intensive studies.
在本综述中,我们总结了近期关于维生素D在甲状腺疾病发生风险中可能作用的观点。从现有数据可以得出结论,维生素D缺乏,尤其是低于12.5 ng/ml的水平,应被视为甲状腺自身免疫性疾病(包括慢性自身免疫性甲状腺炎和格雷夫斯病)发生的一个额外但重要的风险因素。格雷夫斯病发生风险较高还与维生素D结合蛋白编码基因以及活性形式维生素D - 1,25-(OH)(2)D(3)在各自靶细胞中的特异性受体编码基因中的几种多态性有关。甲状腺组织中维生素D受体编码基因以及参与羟化酶编码基因的多态性对甲状腺癌的发生很重要,这会导致局部1,25-(OH)(2)D(3)生成能力降低,进而改变后者的抗增殖、抗凋亡和促分化功效。高剂量维生素D或其类似物的补充是否具有预防或治疗作用是深入研究的对象。